RogerBedimoMD

Infectious Disease • Dallas, TX

Associate Professor, Internal Medicine, University of Texas Southwestern Medical Center, Southwestern Medical School

Join to view full profile

Dr. Bedimo is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Bedimo's full profile

Already have an account?

Office
4500 S Lancaster Rd
Suite 111-D
Dallas, TX 75216
Phone+1 214-857-0397

Fax+1 214-302-1433

Education & Training

University of Alabama Medical CenterFellowship, Infectious Disease, 2001 - 2003
Wright State UniversityResidency, Internal Medicine, 1998 - 2001
University of Yaounde IClass of 1989

Certifications & Licensure

TX State Medical License 2013 - 2026
AL State Medical License 2001 - 2017
OH State Medical License 2001 - 2005
American Board of Internal Medicine Internal Medicine
American Board of Internal Medicine Infectious Disease

Awards, Honors, & Recognition

Member Alpha Omega Alpha, 2001

Clinical Trials

Raltegravir And Darunavir Antiretroviral in Antiretroviral Naive Patients Start of enrollment: 2009 Jan 01
Completed
Phase 4
Integrated Stepped Care for Unhealthy Alcohol Use in HIV Start of enrollment: 2013 Jan 01
Completed
Not Applicable
Long-term Observational Study in HIV Subjects Exposed to EGRIFTA® Start of enrollment: 2013 Feb 01
Terminated
Sofosbuvir-Containing Regimens Without Interferon For Treatment of Acute Hepatitis C Virus (HCV) Infection Start of enrollment: 2014 May 30
Completed
Phase 1
Join now to see all

Publications & Presentations

PubMed

15 citations
The management of treatment-experienced HIV patients (including virologic failure and switches).
James B Cutrell, Tomasz Z. Jodlowski, Roger Bedimo
Therapeutic Advances in Infectious Disease. 2020-01-20
195 citations
Antiretroviral Drugs for Treatment and Prevention of HIV Infection in Adults: 2022 Recommendations of the International Antiviral Society-USA Panel.
Rajesh T Gandhi, Roger Bedimo, Jennifer F Hoy, Raphael J Landovitz, Davey M Smith
JAMA. 2023-01-03
25 citations
Mechanisms of bone disease in HIV and hepatitis C virus: impact of bone turnover, tenofovir exposure, sex steroids and severity of liver disease.
Roger Bedimo, James B Cutrell, Song Zhang, Henning Drechsler, Ang Gao
AIDS. 2016-02-20

Journal Articles

Policy Recommendations for Optimizing the Infectious Diseases Physician-Scientist Workforce
Wendy Armstrong, Ebbing Lautenbach, Kyle J Popovich, C Buddy Creech, Roger Bedimo, Upinder Singh, Jatin M Vyas, The Journal of Infectious Diseases
Skin Disease Prevalence Study in Schoolchildren in Rural Côte D'Ivoire: Implications for Integration of Neglected Skin Diseases (Skin NTDs)
Roger Bedimo, Henning Drechsler, PLoS One

Press Mentions

Theratechnologies Presents New Tesamorelin Data Demonstrating Improvement of Metabolic Syndrome in People with HIVFebruary 22nd, 2023
Infectious Diseases Society of America Announces Next Editor-in-Chief of the Journal of Infectious DiseasesJanuary 11th, 2022
Contemporary Management of HIV: Heavily Treatment–Experienced PatientsDecember 17th, 2020
Join now to see all